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Introduction 
     The objective of this research paper is to illustrate 
the effects of multiple sclerosis (MS) on swallowing and 
dysphagia (i.e., difficulty swallowing). First, the 
discussion will include the definition of MS and its 
physical and emotional affects on people who have this 
diagnosis. Next, the normal swallow and symptoms of 
dysphagia will be discussed. Then, the affects of MS on the 
swallow will be analyzed. Additionally, preferred dysphagia 
assessment procedures will be reviewed. Finally, strategies 
to improve feeding and swallowing for individuals with MS 
will be described.  
What is Multiple Sclerosis 
     MS is one of the most common neurological diseases in 
the world. According to the National Institute of 
Neurological Disorders and Stroke (2011), approximately 
250,000 to 350,000 people in the United States have been 
diagnosed with multiple sclerosis. Worldwide, the incidence 
(defined as a measurement of the number of new individuals 
who contract a disease during a particular period of time)   
of MS is approximately 0.1 percent. Northern Europe, the 
northern United States, southern Australia, and New Zealand 
have the highest prevalence (defined as a measurement of 
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all individuals affected by the disease within a particular 
period of time), with more than 30 cases per 100,000 people 
(Schneider & Swierzewski, 2008). MS is a degenerative 
disease of the central nervous system (CNS), mostly 
affecting the brain and the spinal cord (Rumrill, 2009). MS 
damages the fatty tissue called myelin that surrounds white 
matter tracts in the brain and along the spinal cord 
(Rumrill, 2009). The National Multiple Sclerosis Society 
(NMSS) estimates the prevalence of MS in the United States 
to be between 350,000 and 400,000 cases, indicating that 1 
in 750 people have the diagnosis at any given time (Smith & 
Schapiro, 2004). MS can occur at any age, although initial 
manifestations are most often apparent during early 
adulthood, usually between the ages of 20 and 40. 
Additionally, MS is approximately two or three times more 
common in women than in men (Rumrill, 2009). 
     The exact cause of MS remains unknown but specialists 
generally believe that MS results from a combination of 
immunologic, environmental, and genetic factors resulting 
in an irreversible deterioration of the nerves themselves 
(Schapiro, 2003). Symptoms associated with MS differ 
extensively, and they are primarily determined by the 
location and size of the lesions in the person’s brain and 
spinal cord (Rumrill, 2009). The nature, severity, and 
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number of symptoms related to MS vary widely among 
individuals, and the patterns in which the symptoms appear 
cannot be generalized from one person to another.  
Multiple Sclerosis Symptoms 
     MS is usually characterized by a loss of strength in 
major muscle groups such as those of the arms and legs. One 
of the most common effects of MS is fatigue (Burks & 
Johnson, 2000; Schapiro, 2003), defined as an overwhelming 
sense of tiredness, lack of energy, and feelings of 
exhaustion in excess of what might be expected for the 
associated level of activity (Polman, Thompson, Murray, 
Bowling, & Noseworthy, 2006). Additional key symptoms of MS 
include mobility problems, spasticity, numbness and 
tingling in the extremities, general weakness, visual 
impairments, bowel and bladder dysfunction, sexual 
dysfunction, and cognitive problems (see Table 1).  
     Furthermore, several physiological symptoms are 
related to motor disturbances in people with MS, including 
spasticity (i.e., a disturbance in the coordination of 
muscle contraction and relaxation), and ataxia (i.e., a 
disturbance in mobility coordination) (Burks & Johnson, 
2000; Schapiro, 2003, Rumrill, 2009). Ambulation, the act 
of walking and getting around, is often impaired by such 
symptoms of MS as balance problems, hyperextension of the 
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knees, and instability of the legs (Rumrill, 2009). 
Numbness and tingling in the extremities among people with 
MS can range from “pins and needles” sensations to itching 
in an isolated area of skin or a more severe and painful 
condition termed trigeminal neuralgia (Smith & Schapiro, 
2004). 
     Tremor in the extremities and head is another common 
physiological effect of MS, manifested in a wide range of 
movement from fine, less noticeable tremors to more 
obvious, gross oscillations (Schapiro, 2003). Visual 
impairments in individuals with MS are most often temporary 
conditions that present in blurred or double vision, 
although in some cases functional blindness may result 
(Rumrill, 2009). Bowel and bladder dysfunctions are 
frequent, frustrating, and often embarrassing effects of MS 
(Rumrill, 2009). Sexual dysfunction affects up to 85 
percent of men and up to 74 percent of women diagnosed with 
MS (Foley & Werner, 2004).  
     In addition to MS impairing physiological symptoms, MS 
often has a negative impact of one’s psychological 
functioning. Psychological problems related to MS can be 
divided into three categories: cognitive dysfunctions, 
affective disorders, and adjustmental issues (Rumrill, 
2009). Although once considered symptomatic of only the 
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most severe cases of MS, cognitive dysfunctions have been 
established as a common symptom of all stages and types of 
disease. Smith and Schapiro (2004) and Polman at al. (2006) 
estimated that as many as 60-65 percent of people diagnosed 
with MS experience some degree of measurable cognitive 
change. These changes can affect attention, conceptual 
reasoning, executive function, and memory (Rumrill, 2009). 
     A sizeable proportion of the overall psychological 
impact of MS can be viewed in terms of affective disorders 
that accompany the illness (Rumrill, 2009). The most common 
affective symptoms include irritability, difficulty 
concentrating, anxiety, bipolar disorder, and depression 
(McReynolds & Koch, 2001). Approximately one-half of all 
people with MS experience at least one major depressive 
episode during the course of the illness (McReynolds & 
Koch, 2001). Another common psychological symptom of MS is 
pathological laughing and weeping (Rumrill, 2009). LaRocca 
states that a person with MS may break into laughter or 
begin to weep with slight or no provocation, regardless of 
his or her underlying mood state. Such emotional outbursts 
can be functionally disabling in and of themselves, making 
even basic tasks of daily living extremely difficult to 
perform (as cited in Rumrill, 2009).  
     In addition to the cognitive and affective symptoms of 
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MS, the wide-ranging physiological effects of the illness 
and its unpredictable course make the process of adjusting 
to such a debilitating disease a very difficult task 
(Rumrill, 2009). Kalb and Miller indicate that a number of 
factors influence one’s overall psychological adjustment to 
MS and state that a primary determinant of adjustment is 
the perceived intrusiveness of the illness. This includes 
the cumulative effect of functional deficits, physical 
disabilities, stressful life events, the unique set of 
signs, symptoms, and treatment constraints associated with 
an individual’s condition, life satisfaction, coping style, 
knowledge of MS, personality, and support systems (as cited 
in Rumrill, 2009).         
     As many as 60 to 65 percent of people diagnosed with 
MS undergo some degree of measurable cognitive change as 
estimated by Smith and Schapiro (2004) and Polman et al. 
(2006). These changes can affect attention, conceptual 
reasoning, executive function, and memory (Rumrill, 2009). 
The cognitive dysfunction aspect of MS is often difficult 
to detect since language skills and intellectual function 
are often intact (Barnes, 2010). 
Treatment options 
     There is no cure for MS, but research indicates that 
early treatment of MS delays disability by decreasing the 
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injury to the nervous system caused by the disease (Vishnu, 
2010). Treatment of MS can be categorized by treatment that 
changes the course of disease by modifying the number and 
severity of attacks or treatment addressing symptom 
management (Vishnu, 2010). During an MS attack, 
inflammation occurs in areas of the white matter of the 
central nervous system in random patches called plaques 
(“Multiple Sclerosis”, n.d.). This is followed by 
destruction of myelin, the fatty covering that protects 
nerve cell fibers in the brain and spinal cord. When myelin 
is damaged, neurological transmission of messages may be 
slowed or blocked completely, resulting in diminished or 
lost function (“Multiple Sclerosis”, n.d.).  
     In both treatment options, prescribed drugs are used 
to reduce the number and severity of attacks and to help 
manage the symptoms. The FDA approved six products for 
disease modifying treatments (Vishnu, 2010). These include 
Betaseron® (interferon beta-1b), Avonex® (interferon beta-
1a), Rebif® (interferon beta-1a), Copaxone® (Glatiramer 
Acetate), Tysabri® (Natalizumab), and Novantron® 
(Mitoxantrone)(Vishnu, 2010). Symptom specific management 
involves usage of many drugs. Muscle weakness, numbness and 
stiffness or spasticity is treated with muscle relaxants 
such as tizanidine, baclofen, benzodiazepines (diazepam), 
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and anticonvulsants (carbamazepine) (Vishnu, 2010). The use 
of baclofen and tizanidine demonstrate side effects such as 
drowsiness, dizziness, and fatigue. Side effects of 
cabamazepine include aplastic anemia and low white blood 
cell count (Vishnu, 2010). Fatigue is treated using 
amantadine hydrochloride or modafinil and the side effects 
include nausea, dizziness, and headaches. Balance and 
equilibrium difficulties are treated with benzodiazepines, 
clonazepam, propranolol, and mysoline. Side effects of 
their usage include drowsiness, confusion, and depression 
(Vishnu, 2010).      
How MS Affects Patients and Significant Others 
     MS has many effects on patients and their significant 
others. MS is typically diagnosed in the second and third 
decade of life, when people are usually just beginning to 
become established in their careers and building homes and 
families (Burgess, 2010). The presentation, course, and 
severity of the symptoms experienced of MS vary greatly 
among individuals, as well as the impact of MS on 
individuals with MS and their families (Burgess, 2010).  
     The way in which the diagnosis of MS is communicated 
to the individual and the support provided have a great 
influence on the development of coping mechanisms (Johnson, 
2003). Feelings of abandonment, isolation, anxiety, 
9	  
	  
	  
depression, and anger are universal reactions for both the 
patient and significant others. Effective support at this 
life-changing time is critical (Johnson, 2003). Although 
there are common patterns of responses to a MS diagnosis, 
individual characteristics constitute a critical portion of 
how an individual handles the problem. While feelings of 
grief are common, some people also go through feelings of 
relief when they discover that the diagnosis is not 
something they would consider worse than MS, such as brain 
tumor or motor neuron disease (Johnson, 2003).  
     The needs of partners and family members may be 
overlooked at the diagnosis period. Bogosian, Moss-Morris, 
Yardley, & Dennison (2009) studied the impact of diagnosis 
on partners of people with MS. They found that feelings of 
anger, loss of control, and social isolation were typical. 
The incidence of depression among partners and caregivers 
of people diagnosed with MS is twice as high as that of 
healthy controls (Solari, Ferrari, & Radice, 2006). The 
importance of providing information and continuing support 
to partners and significant others should not be 
underestimated.  
Swallowing 
     Swallowing is a complex sensorimotor function that 
incorporates activity from multiple muscle groups in the 
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upper aerodigestive tract (Crary, Carnaby, & Groher, 2006). 
Countless diseases and conditions affect this basic organic 
function. Therefore, understanding the normal swallow is 
one of the keys to beginning to develop a therapeutic plan 
for the patient with impaired deglutition. Swallowing is a 
complex neurophysiologic process requiring over 40 pairs of 
muscles (Bass, 1997) in four basic phases. The first phase 
is the oral preparatory phase. Food is put into the mouth, 
chewed, and moistened with saliva. Muscles and nerves 
function together to keep food in the mouth and prepare it 
for swallowing. The second phase is the oral phase. The 
food is moved from the mouth to the pharynx or back of the 
throat. The soft palate elevates to keep the food out of 
the nose and the back of the tongue pushes the food back 
into the throat. The tongue and palate are very important 
to this phase. The third phase is the pharyngeal phase. The 
food moves into the esophagus from the pharynx. Breathing 
stops during this part of swallowing in order to prevent 
food from entering the airway (aspiration). The fourth 
phase, the esophageal phase, is the movement of food 
through the esophagus to the stomach (see Table 2). 
Dysphagia 
     Dysphagia is defined as the subjective awareness of 
swallowing difficulty during passage of a solid or liquid 
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bolus from the mouth to the stomach (Sheltman, 2007). When 
patients experience dysphagia, their symptoms can range 
from mild discomfort in the mouth or throat when swallowing 
to an inability to eat. In some patients, dysphagia is 
localized in the phases of deglutition related to the 
mouth, throat, or pharynx, or esophagus while other 
patients may have more complex and extensive damage. 
Dysphagia, if unnoticed and untreated, can lead to 
insufficient oral intake, malnutrition, dehydration, 
inability to take required oral medications, aspiration 
pneumonia, and death (Terrado, Russell, & Bowman, 2001). 
The diagnosis of swallowing disorders is established 
through clinical examination and instrumental examination.  
     Swallowing dysfunctions are regularly observed in 
patients with MS and have been calculated to occur in 33% 
to 43% of the cases (Thomas & Wiles, 1999). The effect of 
dysphagia in patients with MS lowers the quality of their 
life in addition to creating a potential risk of aspiration 
and subsequent bronchopneumonia, a frequent cause of 
morbidity and death in the late stages of MS (Sadovnick, 
Eisen, Ebers, & Paty, 1991).  
     Dysphagia in MS is possibly due to a combination of 
several potential factors, such as involvement of the 
corticobulbar tracts, cerebellar and brainstem 
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dysfunctions, lower cranial nerves paresis, and cognitive 
impairment (Calcagno, Ruoppolo, Grasso, De Vincentiis, & 
Paolucci, 2002). Poorjavad et al. (2010) studied the 
prevalence of different types of swallowing disorders among 
MS patients with mild to moderate disability and found that 
pharyngeal stage disorders were the most common observed 
impairment. 
Assessment of Dysphagia 
     Dysphagia decreases the quality of life in patients 
with MS, and increases the risk of dehydration and 
aspiration. These complications may be avoided with a 
timely swallowing assessment and management plan (Poorjavad 
et al., 2010). Diagnosis of dysphagia can be supported not 
only by case history findings, but also by functional tests 
and instrumental tests such as a videofluoroscopic swallow 
study (VFSS) or a fiberoptic endoscopic examination of 
swallowing (Bergamaschi et al., 2008). Evaluations of 
swallowing function can be conducted using various 
methodologies depending on the stage(s) of the swallow one 
needs to assess and on the clinician’s purpose (McCullough, 
2004). Evaluation approaches of oral, pharyngeal, and 
cervical esophageal function in medical settings typically 
include clinical swallowing examination (CSE), 
videofluoroscopic swallow study (VFSS) otherwise known as 
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the modified barium swallow study (MBSS), and fiberoptic 
endoscopic examination of swallowing (FEES) (McCullough, 
2004). These evaluation approaches include both direct and 
indirect visualization procedures, as follows. 
     The CSE allows a limited examination of a patient’s 
muscle function, sensation, and airway protective functions 
(Murray, 1999). This direct inspection allows the clinician 
to develop a profile of health, disability, or probable 
risk for disability. Oral motor and feeding abilities 
background information can be gathered with the CSE 
(McCullough, 2004). During the CSE, oral structures and 
functions, laryngeal function, posture and movement of 
client, alertness, awareness, ability to follow directions, 
auditory and visual acuity, and strength of voluntary cough 
are observed. The patient is then observed swallowing 
secretions and, provided that was performed adequately, 
small amounts (less than 5 cc) of material of various 
consistencies (Christiansen, 2009). Observation of oral 
bolus control and laryngeal elevation during swallowing is 
performed. Voice quality after swallowing is noted for 
signs of wetness, which may indicate inadequate bolus 
clearance and possible aspiration. Presence of coughing, 
choking, or gagging is noted and, if severe, may be grounds 
for limiting or terminating the clinical/bedside swallowing 
14	  
	  
	  
examination (Christiansen, 2009). Findings from the 
clinical examination are combined with information gathered 
during the historical data collection and interview session 
(Murray, 1999).  
     The VFSS is considered the gold standard for 
thoroughly assessing oral, pharyngeal, and cervical 
esophageal stages of swallowing (McCullough, 2004). The 
VFSS method is considered an ideal tool by many practicing 
SLPs because it allows visualization of the bolus flow and 
structural movement throughout the upper aerodigestive 
tract in real time (Martin-Harris, 2007). The VFSS also 
permits detection of the presence and timing of aspiration 
(i.e., entry of ingested material below the level of the 
true vocal folds into the trachea) and assists in 
identifying the physiologic and often treatable causes of 
the aspiration (Martin-Harris, 2007).  Limitations of this 
method are difficulties related to patient transportation 
and concerns associated with ingestion of the radiation. 
Furthermore, it is rather unnatural because it examines 
swallowing function in ideal conditions with upright 
posturing and coaching and uses boluses that only loosely 
approximate normal food and liquid intake (McCullough, 
Rosenbek, Robbins, Coyle, & Wood, 1998).  
     FEES is the second most commonly applied instrumental 
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technique for the assessment of oropharyngeal swallowing 
function. They go on to state that the FEES permits 
visualization of pharyngeal and laryngeal dynamics prior to 
and following the swallow, allowing for inferences of 
swallowing function to be made based on the presence of 
residue, and permitting the detection of aspiration 
(Martin-Harris, 2007). However, there are several 
limitations to this type of exam. Many of the essential 
physiologic components known to contribute to the synergy 
of a safe and efficient swallowing mechanism are obstructed 
during this endoscopic exam (Langmore et al., 1998). The 
oral cavity cannot be viewed because of the pharyngeal 
position of the scope. Additionally, they dynamics of the 
pharynx, larynx, and cervical esophagus are eliminated at 
the very height of the swallow because the tip of the 
endoscope opposes structures during superior-anterior 
movement of the hyolaryngeal complex (Martin-Harris, 2007). 
Also, the examiner is unable to view the bolus clear 
through the esophagus (Mendell & Logemann, 2002). Each of 
the examinations described has strengths and weaknesses, 
and data to define those strengths and weaknesses are 
continually emerging.  
Management of Dysphagia in Multiple Sclerosis 
     The literature on swallowing problems in patients with 
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MS is rather scarce. Dysphagia often develops in mildly 
impaired MS patients, and becomes a frequent finding in MS 
patients with moderate to severe disability (Bogaardt et 
al., 2009). Dysphagia in patients with MS presents problems 
with various consistencies of food. Patients with a mild 
stage of MS are likely only to develop problems with 
swallowing fluids, whereas patients with a more advanced 
stage also develop problems with swallowing solid foods (De 
Pauw, Dejaeger, D’hooghe, & Carton, 2002). Currently, the 
treatment options for restoring and maintaining swallowing 
function in patients with MS are rather limited (De Pauw, 
Dejaeger, D'hooghe, & Carton, 2002). When managing 
dysphagia, the individual’s team aims to maintain adequate 
nutrition, hydration, and ingestion of oral medications 
while preventing aspiration. Generally strategies to 
improve feeding and swallowing include diet modification, 
adjustment of the environment, and patient education on 
compensatory techniques to use during meals or whenever 
swallowing (Terrado et al., 2001). 
     Diet modification or restrictions are determined by 
the viscosity or volume of the bolus the patient aspirates. 
The National Dysphagia Diet (NDD) provides a progressive 
system of textural standards for solid and liquids for use 
in dysphagia management (Terrado et al., 2001). The NDD 
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includes four levels for liquids and four for semi-solid 
food textures (Terrado et al., 2001). The levels of liquids 
are thin, nectar-like, honey-like, and spoon-thick. Thin 
liquids are low viscosity liquids that include clear 
liquids, milk, most liquid nutritional supplements, water, 
tea, coffee, soda, beer, wine, broth, ice cream, plain 
gelatin, clear juice, and frozen yogurt (Terrado et al., 
2001). Nectar-like liquids are medium viscosity liquids 
including nectars, vegetable juices, and milkshakes without 
thickeners (Terrado et al., 2001). Honey-like liquids have 
a consistency of honey and typically involve the use of a 
commercial thickener added using package instructions to 
bring any beverage to this level of thickness. Spoon-thick 
liquids are high viscosity liquids that are too thick for a 
straw. Commercial thickeners similar to pudding can be 
added to any beverage to obtain this level of thickness 
(Terrado et al., 2001).  
     The levels of semi-solid and solid foods are: pureed, 
mechanically altered, mechanically soft, and regular 
(Terrado et al., 2001). Pureed food is homogenous, 
consistent, and pudding-like, requiring very little chewing 
ability. Mechanically altered food is cohesive, moist, 
semi-solid foods; requiring some chewing ability. 
Mechanically soft food is soft-solid foods that require 
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more chewing ability. Finally, regular food is when all 
foods are allowed (Terrado et al., 2001). The textures of 
foods play a vital role when managing dysphagia. Often 
times the ability to process specific textures is decreased 
by oral-preparatory and oral-stage deficits. Inadequately 
chewed food may impair digestion in the lower portion of 
the digestive system as well as provide opportunities for 
aspiration or air-way obstruction (Terrado et al., 2001). 
The goal of an accurate assessment and correct selection of 
diet textures is to improve nutritional intake as well as 
swallowing safety.  
     When the dysphagia diet is prescribed, patients may 
exhibit a negative reaction. Their enjoyment of food may 
disappear and they may avoid socialization at meal-times. 
In order to persuade patients to eat sufficient amounts of 
food to meet nutrition and hydration requirements, items 
should be flavorful and appear appetizing. Therefore, 
special attention to food preparation for correct textures 
and seasonings as well as plate presentation is important 
(Terrado et al., 2001). 
     The mealtime environment should be pleasant and set up 
to maximize concentration and attention on the task of 
feeding and swallowing. Any distractions such as 
television, radio, or other environmental stimuli should be 
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adjusted to maximize attention to feeding. Conversation 
during meals should be minimized. Staff, family members, or 
other visitors should be taught to limit conversation where 
the patient may be expected to respond between sips or 
bites (Terrado et al., 2001). Speaking requires the 
expulsion of air through an open airway; if the individual  
with dysphagia attempts to speak with food or liquid in the 
mouth, or is distracted from using compensatory strategies, 
the risk of aspiration is increased (Terrado, et al., 
2001). Therefore, conversation during meals should be 
limited and verbal cueing for swallowing to the patient 
should be provided. Patients who are emotionally labile 
(e.g., talking, humming, laughing, or crying 
inappropriately during meals) are at risk for aspiration 
and need reminders to stop these behaviors while 
swallowing. When patients are placed on aspiration 
precautions, they should not be left alone during meals 
(Terrado, et al., 2001). It is essential to provide good 
oral hygiene (i.e., brushing the teeth, gums, palate, and 
tongue) before and after meals to reduce the bacteria in 
the mouth that, if aspirated with the foods, liquids, or 
saliva, increase the risk of aspiration pneumonia (Terrado 
et al., 2001). 
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Psychosocial issues 
     The psychosocial impact of swallowing disorders is a 
critical component and should be addressed in a treatment 
plan (Terrado et al., 2001). Dysphagia represents a major 
disruption in the social aspect of meals, such as eating 
with friends or family, eating in restaurants, attending 
social events that involve meals, or holiday gatherings. 
Eating is no longer a simple, pleasant activity but a 
stressful and possibly challenging task. Individuals with 
dysphagia may be embarrassed by their impairments or self-
conscious of their lack of autonomy for such a basic 
function (Terrado, et al., 2001). To avoid public 
discomfort, they will often choose to eat alone. Caregivers 
should encourage self-feeding whenever possible. Various 
assistive devices such as rubber mats or other non-skid 
surfaces to keep plates in place, broad-based cups and 
high-rimmed plates to prevent spills, and thick-handled 
utensils facilitate self-feeding (Terrado et al., 2001). 
     Compensatory strategies are used to improve the 
symptoms of dysphagia. These techniques generally require 
the patient to position the head and body to control the 
flow of foods or liquids, modify the consistency and volume 
of food, and modify the rate at which food is given. The 
chin tuck and effortful swallow are two specific 
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compensatory strategies for patients with MS (Restive, 
Marchese-Ragona, & Patti, 2006). A chin tuck is total 
flexion of the cervical spine with chin down to chest. 
Patients are often asked to “look at the belly button” to 
help ensure proper head position when swallowing a bolus. 
Unless otherwise indicated, the patient should always sit 
upright at 90 degrees with the head in neutral position. 
The patient should remain sitting upright or the head of 
the bed kept elevated for 30 to 45 minutes after eating 
(Terrado et al., 2001). Postural adaptations are generally 
used short term until the patient's swallow function 
returns or until there is significant improvement after 
therapy. If there is permanent neurologic or structural 
damage, these adaptations are used long term to reduce 
incidence of aspiration (Terrado et al., 2001).  
     The effortful swallow increases the tongue driving 
force by causing exaggerated retraction of the tongue. This 
helps to get food past the valleculae. The patient is 
directed to squeeze hard with his throat and neck muscles 
during the swallow (Logemann, 1997). Specific swallowing 
techniques change the swallow physiology to reduce the risk 
of food or liquids passing below the vocal folds and 
entering the trachea (Emick-Herring & Wood, 1990). Using 
these techniques, the patient can voluntarily protect the 
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airway before the pharyngeal swallow is triggered, thus 
minimizing aspiration (Terrado et al., 2001). 
     Meals should be visually pleasing and attractive to 
stimulate smell, taste, appetite and salivary production 
(Martin, Holt, & Hicks, 1981). If a patient is intimidated 
by large servings or becomes fatigued before completing 
meals, the patient may prefer eating small amounts of food 
at frequent intervals. These patients are more likely to 
finish foods presented in attractive small size portions, 
developing a greater sense of satisfaction and achievement, 
particularly at the beginning of a feeding program (Terrado 
et al., 2001). Additionally, food bites should be large 
enough to require chewing but small enough to manage. For 
the majority of patients, providing medium-sized bites (15 
ml or 1 teaspoonful) is sufficient to trigger the 
pharyngeal swallow. However, for patients with oral stage 
impairments, a spoon, with a 1/4 to 1/3 teaspoonful bolus, 
is placed firmly on the center of the tongue, and then the 
patient removes the bolus with the lips (Terrado et al., 
2001). The pressure of the spoon on sensitive areas of the 
tongue aids mouth closure and propulsion of the bolus 
backward (Groher, 1997). To promote optimal nutrition, more 
solid foods should be offered first; liquids should not be 
used to “push” down the solids since moving food too 
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quickly may increase the potential for aspiration (Terrado 
et al., 2001).  
     Patients and family members need ample education and 
support to understand and follow diet and swallowing 
recommendations vital to the safety of the patient with 
dysphagia. For example, showing the patient and family 
members a videotape about the instrumental test helps them 
understand why changes in diet or modifying the method of 
swallowing can be helpful. At times, patients and family 
members may choose not to follow diet and swallowing 
recommendations. Patients have the right to refuse 
dysphagia management but they should be well informed about 
that decision’s potential consequences (malnutrition, 
aspiration, and death). 
Conclusion 
     In conclusion, the objective of this research paper 
was to describe dysphagia in MS. The impact of MS on the 
individual and their families were examined. Next, the 
stages of a normal swallow were explained, including 
symptoms of dysphagia. Therefore, current literature 
regarding symptoms, assessment, and management of dysphagia 
associated with MS were explored. Additionally, the effects 
of dysphagia on MS were discussed, including the cause of 
dysphagia when related to MS and possible compensatory 
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strategies that can be utilized. Finally, strategies to 
improve feeding and swallowing for individuals with MS and 
dysphagia were discussed. Further research is warranted to 
display recent advancements made in therapy with regard to 
dysphagia and MS. 
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Table 1   
 
Common Symptoms of Multiple Sclerosis as described by Merck 
& Co., Inc. (2010). 
 
Part of the Body Examples 
Nerves (affecting sensation) Numbness, Tingling, Reduced 
sense of touch, Pain or 
Burning, Itching 
Eyes Double vision, Partial 
blindness and pain in one 
eye, Dim or blurred vision, 
Inability to see while 
looking straight ahead, 
Uncoordinated eye movements 
Muscles and coordination Weakness and clumsiness, 
Difficulty walking or 
maintaining balance, Tremor, 
Uncoordinated movements, 
Stiffness, unsteadiness, 
unusual fatigue 
Mood Mood swings, Inappropriate 
elation or giddiness, 
Depression, Inability to 
control emotions 
Brain Subtle or obvious mental 
impairment, Memory loss, Poor 
judgment, Inattention 
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Table 2 
 
Phases of the normal swallow as described by Mizuko, 
Hatten, Kamarek, Piette, & Stone (2010). 
Phase of Swallow Example 
Oral Preparatory Phase Food is manipulated in mouth 
and masticated (chewed) if 
necessary in order to reduce 
food to consistency that can 
be swallowed. 
Oral Phase Tongue propels food 
posteriorly until pharyngeal 
swallow is triggered. 
Pharyngeal Phase Bolus (cohesive ball of food) 
is transported through 
pharynx. 
Esophageal Phase Esophageal peristalsis 
carried bolus from upper 
esophageal sphincter (UES) 
through esophagus to lower 
esophageal sphincter (LES). 
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